Complication of methotrexate-maintained remission in lymphoblastic leukemia.
D000667:Ampicillin / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000188:drug therapy; D002648:Child; D003023:Cloxacillin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D001239:Inhalation; D007273:Injections, Intramuscular; D002955:Leucovorin / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008168:Lung / Q000473:pathology; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D011014:Pneumonia / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D000667:Ampicillin; D003023:Cloxacillin; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate